Report an accessibility problem

2023 National Academy of Medicine Catalyst Awards

Sponsors:
National Academy of Medicine
Amount:
$50,000
External Deadline:
02/27/23
Opportunity Information:

The National Academy of Medicine (NAM), with support from Johnson & Johnson Innovation, the Bia-Echo Foundation, and the Yun Family Foundation invites applications to the 2023 US NAM Catalyst Award competition.

NAM invites bold, new, and innovative ideas that aim to extend the human health span (i.e., the number of years lived in good health), especially approaches that challenge existing paradigms or propose new methodologies or concepts. High-risk ideas that could potentially yield high rewards and, in turn, dramatically change the field of healthy longevity are encouraged. Each Catalyst Award includes a $50,000 cash prize, exclusive access to additional funding opportunities, occasions to connect and collaborate with innovators from around the world, and amplification of the award and winning idea. 

Applications may originate from any field or combination of fields (e.g., biology, chemistry, medicine, engineering, behavioral and social sciences, technology, data science, and policy). Examples of topic areas include but are not limited to behavioral health (e.g., social connectedness, engagement, and well-being); biology of aging and molecular pathways; built environment and urban planning; disease prevention, including biomarkers and indicators of disease; health care delivery (e.g., technologies simplifying access to care, elder care services); housing (e.g., smart-enabled homes, intergenerational housing models); physical health (e.g., mobility and functionality); policy (e.g., economic, health, and science); reproductive longevity and equality; and technology (e.g., artificial intelligence; robotics; medical, assistive, and information technology).

NAM accepts applications from any United States-based organization (e.g., colleges and universities, government laboratories, research institutions, nonprofit organizations, and for-profit companies). For-profit companies, in particular, cannot have annual sales revenues of more than $10 million for each of their last two fiscal years. There is a strong preference for early-stage endeavors (e.g., seed investments, startups, social enterprises, and spinouts). The principal investigator must reside in the U.S. as a U.S. citizen, legal resident alien, or non-resident alien with a valid visa. Co-PIs are not required to reside in the U.S. 

For complete program guidelines and application instructions, see the National Academy of Medicine website.

ASU Information:

Submissions to this sponsor/donor are managed by the Office of Corporate and Foundation Relations. Please contact your unit-assigned ASUF Director of Development or Research Advancement Specialist at your earliest convenience to ensure ASU's strategic coordination and management of funding applications.

Posted Date: